JINZHEN for Treatment of Mild to Moderate COVID-19

NCT05092503 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: JINZHEN Granules for Oral Solution
DRUG: Placebo

Sponsor

Lianyungang Kanion Group, Ltd.